PD-L2 (Protein | Antibody | cDNA Clone | ELISA Kit)

All PD-L2 reagents are produced in house and quality controlled, including 10 PD-L2 Antibody, 1 PD-L2 ELISA, 52 PD-L2 Gene, 9 PD-L2 Lysate, 11 PD-L2 Protein, 3 PD-L2 qPCR. All PD-L2 reagents are ready to use.

More Product Popular With Customers

PD-L2 Background

Programmed death ligand 2 (PD-L2), also referred to as B7-DC and CD273, is a member of the B7 family of proteins including B7-1, B7-2, B7-H2, B7-H1 (PD-L1), and B7-H3. PD-L2 is a type I membrane protein and structurally consists of an extracellular region containing one V-like and one C-like Ig domain, a transmembrane region, and a short cytoplasmic domain. PD-L2 is expressed on antigen presenting cells, placental endothelium and medullary thymic epithelial cells, and can be induced by LPS in B cells, INF-γ in monocytes, or LPS plus IFN-γ in dendritic cells. The CD28 and B7 protein families are critical regulators of immune responses. PD-L2 and PD-L1 are two ligands for PD-1, member of the CD28/CTLA4 family expressed on activated lymphoid cells, and thus provide signals for regulating T cell activation and immune tolerance. The interaction of B7-DC/PD-1 exhibited a 2-6-fold higher affinity compared with the interaction of B7-H1/PD-1.

PD-L2 References

  • Latchman Y, et al. (2001) PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol. 2: 261-8.
  • Carreno BM, et al. (2005) Therapeutic opportunities in the B7/CD28 family of ligands and receptors. Curr Opin Pharmacol. 5(4): 424-30.
  • Radhakrishnan S, et al. (2007) B7-DC/PD-L2 cross-linking induces NF-kappaB-dependent protection of dendritic cells from cell death. J Immunol. 178(3): 1426-32.
彩票大奖得主捐赠 河南配资炒股 体彩浙江6 1开奖结果查询 北京11选5走势一定牛 佳永配资 有河南快3的平台 股票分析论文 黑龙江11选5预测专家推荐 贝得来配资 好运彩官网 上证银行指数